Related Experiment Video
Updated: Sep 3, 2025

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
Modeling the Competition between Misfolded Aβ Conformers That Produce Distinct Types of Amyloid Pathology in
Guilian Xu1,2,3, Susan Fromholt1,2,3, David R Borchelt1,2,3
1Department of Neuroscience, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
Abstract:
The amyloid pathology characteristic of Alzheimer's disease (AD) can be broadly classified as either fibrillary amyloid or diffuse amyloid. Fibrillary amyloid is found in cored-neuritic deposits, fibrillar deposits, and vascular deposits, and binds strongly to the amyloid revealing dyes Thioflavin-S or Congo Red. Diffuse amyloid can appear as wispy dispersed deposits or compact tufted deposits dispersed in neuropil, and binds amyloid dyes weakly if at all. In AD brains, both types of pathology are detected. Homogenates from AD brains, or the brains of transgenic mice modeling AD-amyloidosis, have been used to seed pathology in vulnerable host transgenic models. These studies suggest that pathologies may arise from distinct conformers or strains of misfolded Aβ, similar to propagating prions. Using Aβ strains sourced from four different AD-amyloidosis models, we injected pathological seeds into the brains of newborn mice from three different transgenic hosts with distinctive Aβ pathologies. Two of the seeding sources were from mice that primarily develop cored-neuritic Aβ deposits (cored strain) while the other two seeding sources were from mice that develop diffuse Aβ deposits (diffuse strain). These seeds were injected into host APP mice in which the resident strain was either diffuse or cored-neuritic pathology. Seeding-homogenates were injected into the brains of newborn mice to initiate propagation as early as possible. Depending upon the level of transgene expression in the host, we show that the injected strains of misfolded Aβ from the seeding homogenate were able to outcompete the resident strain of the APP host model. In serial passaging experiments, it appeared that the diffuse strain was more easily propagated than the cored strain. Collectively, our studies align with the idea that different types of Aβ pathology in AD brains arise from different populations of Aβ conformers that compete to populate the brain.
Insights
Alzheimer's disease (AD) amyloid pathology may stem from distinct misfolded amyloid-beta (Aβ) conformers, akin to prions. These Aβ strains can compete and propagate within the brain, influencing AD progression.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Alzheimer's disease (AD) is characterized by amyloid-beta (Aβ) pathology, presenting as fibrillary or diffuse deposits.
- These Aβ pathologies exhibit differential binding affinities to amyloid dyes like Thioflavin-S and Congo Red.
- Evidence suggests that distinct Aβ conformers or strains may propagate pathology, similar to prions.
Purpose of the Study:
- To investigate the propagation and competition dynamics of different Aβ strains in vivo.
- To determine if distinct Aβ conformers can outcompete resident pathologies in transgenic mouse models of AD-amyloidosis.
Main Methods:
- Injected distinct Aβ strains (cored-neuritic and diffuse) from AD models into newborn transgenic mice.
- Utilized three different transgenic host models with varying resident Aβ pathologies (diffuse or cored-neuritic).
- Performed serial passaging experiments to assess strain propagation efficiency.
Main Results:
- Injected Aβ strains successfully propagated and, depending on host transgene expression, outcompeted resident pathologies.
- The diffuse Aβ strain demonstrated more efficient propagation compared to the cored-neuritic strain.
- Strain competition dynamics were observed, suggesting a hierarchy in Aβ conformer propagation.
Conclusions:
- Different Aβ pathologies in AD brains likely arise from distinct Aβ conformer populations.
- These Aβ conformers compete to establish pathology, influencing disease progression.
- Understanding Aβ strain diversity is crucial for developing targeted AD therapies.
More Related Videos
08:25Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
Published on: April 19, 2021
08:01Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...